IL153641A0 - Human myeloma cell line - Google Patents

Human myeloma cell line

Info

Publication number
IL153641A0
IL153641A0 IL15364101A IL15364101A IL153641A0 IL 153641 A0 IL153641 A0 IL 153641A0 IL 15364101 A IL15364101 A IL 15364101A IL 15364101 A IL15364101 A IL 15364101A IL 153641 A0 IL153641 A0 IL 153641A0
Authority
IL
Israel
Prior art keywords
myeloma cell
cell line
human myeloma
human
producing
Prior art date
Application number
IL15364101A
Other languages
English (en)
Original Assignee
Univ Cambridge Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0016824A external-priority patent/GB0016824D0/en
Priority claimed from GB0017139A external-priority patent/GB0017139D0/en
Application filed by Univ Cambridge Tech filed Critical Univ Cambridge Tech
Publication of IL153641A0 publication Critical patent/IL153641A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL15364101A 2000-07-07 2001-07-09 Human myeloma cell line IL153641A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0016824A GB0016824D0 (en) 2000-07-07 2000-07-07 Human monoclonal antibodies
GB0017139A GB0017139D0 (en) 2000-07-12 2000-07-12 Human monoclonal antibodies
US27058801P 2001-02-23 2001-02-23
PCT/GB2001/003059 WO2002004607A1 (en) 2000-07-07 2001-07-09 Human myeloma cell line

Publications (1)

Publication Number Publication Date
IL153641A0 true IL153641A0 (en) 2003-07-06

Family

ID=27255800

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15364101A IL153641A0 (en) 2000-07-07 2001-07-09 Human myeloma cell line

Country Status (12)

Country Link
US (1) US7387873B2 (enExample)
EP (1) EP1299524B1 (enExample)
JP (1) JP2004502454A (enExample)
KR (1) KR20030022850A (enExample)
CN (1) CN100497601C (enExample)
AT (1) ATE440945T1 (enExample)
AU (2) AU2001269300B2 (enExample)
CA (1) CA2415484A1 (enExample)
DE (1) DE60139694D1 (enExample)
IL (1) IL153641A0 (enExample)
NO (1) NO20030019L (enExample)
WO (1) WO2002004607A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004502454A (ja) 2000-07-07 2004-01-29 ケンブリッジ・ユニヴァーシティ・テクニカル・サーヴィシズ・リミテッド ヒト骨髄腫細胞系
AU2002357932A1 (en) 2001-12-18 2003-06-30 Whitehead Institute For Biomedical Research Fusion partner cells and uses thereof
US8678046B2 (en) 2009-09-20 2014-03-25 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8460745B2 (en) * 2009-09-20 2013-06-11 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US20110070358A1 (en) * 2009-09-20 2011-03-24 Medtronic Vascular, Inc. Method of forming hollow tubular drug eluting medical devices
US8333801B2 (en) 2010-09-17 2012-12-18 Medtronic Vascular, Inc. Method of Forming a Drug-Eluting Medical Device
US8616040B2 (en) 2010-09-17 2013-12-31 Medtronic Vascular, Inc. Method of forming a drug-eluting medical device
CN105601734A (zh) * 2016-03-01 2016-05-25 广东医学院附属医院 一种从人外周血记忆性b淋巴细胞制备抗体的方法
CN115161311B (zh) * 2022-08-22 2025-05-06 广东忠信生物科技有限公司 高效筛选分泌单克隆抗体的杂交瘤细胞的方法及其应用
CN115463146B (zh) * 2022-10-14 2024-01-23 浙大城市学院 哇巴因化合物作为在制备抗病毒药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3379055D1 (en) * 1982-06-09 1989-03-02 Asahi Chemical Ind Method for producing human antibody
US4720459A (en) * 1985-02-14 1988-01-19 Medical College Of Wisconsin Research Foundation, Inc. Myelomas for producing human/human hybridomas
JP2004502454A (ja) 2000-07-07 2004-01-29 ケンブリッジ・ユニヴァーシティ・テクニカル・サーヴィシズ・リミテッド ヒト骨髄腫細胞系

Also Published As

Publication number Publication date
CA2415484A1 (en) 2002-01-17
DE60139694D1 (de) 2009-10-08
AU6930001A (en) 2002-01-21
CN1455813A (zh) 2003-11-12
ATE440945T1 (de) 2009-09-15
US20040023339A1 (en) 2004-02-05
KR20030022850A (ko) 2003-03-17
US7387873B2 (en) 2008-06-17
CN100497601C (zh) 2009-06-10
EP1299524B1 (en) 2009-08-26
WO2002004607A1 (en) 2002-01-17
JP2004502454A (ja) 2004-01-29
AU2001269300B2 (en) 2006-06-22
NO20030019D0 (no) 2003-01-03
EP1299524A1 (en) 2003-04-09
NO20030019L (no) 2003-03-07

Similar Documents

Publication Publication Date Title
YU28503A (sh) Humanizovana anti-lt-beta-r antitela
MXPA03001590A (es) Anticuerpos para la il-1beta humana.
IL161705A0 (en) Human monoclonal antibodies to dendritic cells
IL156030A0 (en) Humanized antibodies
EP1519747A4 (en) HUMAN MONOCLONAL ANTIBODIES AGAINST PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)
HUP0402066A3 (en) Cells producing antibody compositions
AU2003257850A8 (en) Antibody specific to central tau-protein
EP1881064A3 (en) HCV-Anti-core monoclonal antibodies
AU6930001A (en) Human myeloma cell line
ZA200007458B (en) Method of preparing a fuel cell.
BR0015872A (pt) Agentes antitrombóticos
HUP0300142A3 (en) Monoclonal antibodies specific to the human ldl receptor, their production and use
PL361803A1 (pl) Sposób zobojętniania popiołu, sztuczna pucolana otrzymana przy użyciu wymienionego sposobu
AU2001280368A1 (en) Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotherapy
NO20015285L (no) Fremstillingsprosess for n¶ringsmiddelfermenterende midler
AU2001254864A1 (en) Cell culture method, cell cluster obtained by said methods and use thereof
AU5664601A (en) A process for generating cytoplasmic male sterile line in rice and other crops by rna editing
ZA200200730B (en) Human monoclonal antibodies to prostate specific membrane antigen.
GB0016824D0 (en) Human monoclonal antibodies
GB0017139D0 (en) Human monoclonal antibodies
GB0003359D0 (en) Monoclonal antibodies
GB0008160D0 (en) Monoclonal antibodies
DE59913949D1 (de) Humane monoklonale antikörper gegen inselzellantigen ia-2
HK1096725A (en) Immunoassays, haptens, immunogens and antibodies for anti-hiv therapeutics
GB0029846D0 (en) Monoclonal antibody